Product Images Exforge Hct
View Photos of Packaging, Labels & Appearance
- amlodipine structural formula - exforge hct 01
- Valsartan structural formula - exforge hct 02
- Hydrochlorothiazide structural formula - exforge hct 03
- Figure 1: Reduction in Mean Blood Pressure at Endpoint - exforge hct 04
- Figure 2: Mean Sitting Diastolic Blood Pressure by Treatment and Week - exforge hct 05
- Figure 3: Mean Sitting Systolic Blood Pressure by Treatment and Week - exforge hct 06
- Figure 4: Mean Ambulatory Diastolic Blood Pressure at Endpoint by Treatment and Hour - exforge hct 07
- Figure 5: Mean Ambulatory Systolic Blood Pressure at Endpoint by Treatment and Hour - exforge hct 08
- PRINCIPAL DISPLAY PANELPackage Label – 5 mg / 160 mg / 12.5 mgRx Only NDC 0078-0559-15Exforge HCT® (amlodipine, valsartan, hydrochlorothiazide)5 mg* / 160 mg / 12.5 mg*each tablet contains 6.9 mg of amlodipine besylate30 Tablets - exforge hct 09
- exforge hct 10
- exforge hct 11
- exforge hct 12
- exforge hct 13
Product Label Images
The following 13 images provide visual information about the product associated with Exforge Hct NDC 0078-0561 by Novartis Pharmaceuticals Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
amlodipine structural formula - exforge hct 01
Valsartan structural formula - exforge hct 02
Hydrochlorothiazide structural formula - exforge hct 03
Figure 1: Reduction in Mean Blood Pressure at Endpoint - exforge hct 04
Figure 2: Mean Sitting Diastolic Blood Pressure by Treatment and Week - exforge hct 05
The text provides a chart displaying Mean Sitting Diastolic Blood Pressure (DBP) in mmHg, with various treatment options including AMNAHCTZ, ValHCTZ, and HCTZAMI, along with their respective dosages.*
Figure 3: Mean Sitting Systolic Blood Pressure by Treatment and Week - exforge hct 06
Figure 4: Mean Ambulatory Diastolic Blood Pressure at Endpoint by Treatment and Hour - exforge hct 07
Figure 5: Mean Ambulatory Systolic Blood Pressure at Endpoint by Treatment and Hour - exforge hct 08
PRINCIPAL DISPLAY PANELPackage Label – 5 mg / 160 mg / 12.5 mgRx Only NDC 0078-0559-15Exforge HCT® (amlodipine, valsartan, hydrochlorothiazide)5 mg* / 160 mg / 12.5 mg*each tablet contains 6.9 mg of amlodipine besylate30 Tablets - exforge hct 09
exforge hct 10
exforge hct 11
exforge hct 12
This appears to be a description of a medication prescribed for high blood pressure, consisting of a combination of amlodipine, valsartan, and hydrochlorothiazide. The medication is produced by Novartis and is available in pack size of 30 tablets. The dosage of amlodipine is 10mg, valsartan is 160mg, and hydrochlorothiazide is 25mg per tablet. The text also includes a product code, NOC 078.05 and a GTIN code, 0030078052157.*
exforge hct 13
This is a description of a medication called Twynsta HCT. It's a combination of amlodipine, valsartan, and hydrochlorothiazide tablets used to treat hypertension. The tablets are taken orally and come in a bottle containing 30 tablets. The dosage strength is 10mg of amlodipine, 320mg of valsartan, and 25mg of hydrochlorothiazide. The manufacturer is Novartis.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
